GILEAD SCIENCES, INC. Financing Cash Flow 2007-2026 | GILD
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is GILEAD SCIENCES, INC.'s current financing cash flow?
GILEAD SCIENCES, INC. (GILD) annual financing cash flow for 2025 was $-7.75B, a 125.60% decline from 2024. GILEAD SCIENCES, INC. financing cash flow for the quarter ending March 31, 2026 was $-4.24B.
What was GILEAD SCIENCES, INC.'s financing cash flow in 2024?
GILEAD SCIENCES, INC. annual financing cash flow for 2024 was $-3.43B, a 33.01% increase from 2023.
What was GILEAD SCIENCES, INC.'s financing cash flow in 2023?
GILEAD SCIENCES, INC. annual financing cash flow for 2023 was $-5.13B, a 20.78% increase from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$770.0M
→
FY2025
$-7.75B
07080910111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-7.75B | -125.6% | 10-K |
| FY2024 | $-3.43B | +33.0% | 10-K |
| FY2023 | $-5.13B | +20.8% | 10-K |
| FY2022 | $-6.47B | +27.1% | 10-K |
| FY2021 | $-8.88B | -1252.9% | 10-K |
| FY2020 | $770.0M | +110.1% | 10-K |
| FY2019 | $-7.63B | +38.0% | 10-K |
| FY2018 | $-12.32B | -463.0% | 10-K |
| FY2017 | $3.39B | +134.9% | 10-K |
| FY2016 | $-9.72B | -65.3% | 10-K |
| FY2015 | $-5.88B | -94.5% | 10-K |
| FY2014 | $-3.02B | -18.9% | 10-K |
| FY2013 | $-2.54B | -551.9% | 10-K |
| FY2012 | $563.0M | -68.1% | 10-K |
| FY2011 | $1.76B | +231.7% | 10-K |
| FY2010 | $-1.34B | -27.3% | 10-K |
| FY2009 | $-1.05B | +28.7% | 10-K |
| FY2008 | $-1.47B | -762.4% | 10-K |
| FY2007 | $-171.0M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →